Edition:
United States

Daxor Corp (DXR.A)

DXR.A on American Stock Exchange

5.14USD
19 Sep 2017
Change (% chg)

-- (--)
Prev Close
$5.14
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
709
52-wk High
$9.80
52-wk Low
$5.06

Chart for

About

Daxor Corporation is an investment company with medical instrumentation and biotechnology operations. The Company engages in the short selling of stock. The Company maintains a diversified securities portfolio, which consists primarily of the common and preferred stocks of electric utility companies. It has approximately 70... (more)
No analyst recommendations are available for .

Overall

Beta: 0.21
Market Cap(Mil.): $19.67
Shares Outstanding(Mil.): 3.83
Dividend: 0.03
Yield (%): 0.58

Financials

  Industry Sector
P/E (TTM): -- 178.13 16.25
EPS (TTM): -- -- --
ROI: -- 9.49 14.87
ROE: -- 14.72 13.89

BRIEF-Daxor Corp hires John Wilkens as CFO effective immediately

* Daxor corporation announces hiring of chief financial officer

May 31 2017

BRIEF-Daxor not in compliance with NYSE market listing standards

* Daxor- Not in compliance with nyse market listing standards related to timing of sec filings due to delay in filing N-CSR for fiscal year ended Dec. 31, 2016

Apr 10 2017

Earnings vs. Estimates

No consensus analysis data available.